Corient Capital Partners’s AB InBev BUD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-5,137
Closed -$309K – 696
2022
Q1
$309K Buy
5,137
+126
+3% +$7.77K 0.02% 531
2021
Q4
$303K Buy
+5,011
New +$292K 0.02% 512
2021
Q3
– Sell
-3,541
Closed -$255K – 702
2021
Q2
$255K Buy
+3,541
New +$258K 0.02% 539
2016
Q4
– Sell
-2,072
Closed -$272K – 309
2016
Q3
$272K Buy
+2,072
New +$262K 0.05% 261

Other funds holding BUD

Corient Capital Partners's BUD Position: Q2 2022 in Review

Corient Capital Partners sold out of AB InBev (BUD) in Q2 2022, closing a stake of 5,137 shares — an estimated $309K sold.

Corient Capital Partners first reported a position in BUD in Q3 2016 and held it in 4 quarters. The position peaked at $309K in Q1 2022. 513 funds tracked by Wall St. Rank hold BUD as of Q2 2022.

  • Corient Capital Partners reported no remaining AB InBev position as of Q2 2022 after selling out during the quarter.
  • Corient Capital Partners sold 5,137 AB InBev shares in Q2 2022, an estimated $309K.
  • Corient Capital Partners first reported a position in AB InBev in Q3 2016 and held it in 4 quarters.
  • Corient Capital Partners's AB InBev position peaked at $309K in Q1 2022.
  • 513 funds tracked by Wall St. Rank held AB InBev as of Q2 2022.

Based on Corient Capital Partners's 13F filing for Q2 2022, filed 12 Aug 2022.